Institutional Ownership Aligos Therapeutics, Inc. (ALGS)
This table provides information about the institutional ownership of Aligos Therapeutics, Inc. (ALGS). We have compiled data on the 2 institutions that hold shares in the stock, with a total of 227,496 shares, which have been reported (via 13F filing form) to have a value of $1.51 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
227,406
shares
|
$1.51 Million
0.0% of portfolio
|
Q2 2024
Reduced 25.14%
|
|
|
Triumph Capital Management
|
Nov 14, 2025 Q3 2025 |
90
shares
|
$596
0.0% of portfolio
|
Q3 2025
New holding
|